As a forward-thinking founder of and CEO at Adelle Diagnostics, Inc., I lead the company's strategic direction by shaping innovative research plans and implementing effective business strategies. My role involves fostering customer development, analyzing market dynamics, and overseeing diverse operational facets to ensure optimal company performance. Additionally, I manage external communications and facilitate private-public partnerships and fundraising. My career journey has been marked by extensive experience in academia and biomarker research, where I have seamlessly transitioned through various roles. I have a proven track record in imparting knowledge, having developed and taught a successful biomarker and entrepreneurship summer course for pre-college students. My expertise encompasses a range of technical specialties, including immunology, oncology, immuno-oncology, tumor microenvironment, immune tolerance, regulatory T cell biology, inflammation, bone biology, and cell signaling. In the realm of clinical trials, I possess comprehensive knowledge of French and international regulations, spanning selection, implementation, monitoring, and closure. My skills extend to cell culture methods, mouse models, molecular biology (including RNAi and classical immunomonitoring techniques), confocal and 2-photon imaging techniques, as well as transcriptome and data analysis. My commitment to driving success through a multidisciplinary approach, coupled with a deep understanding of industry regulations and cutting-edge technologies, positions me as a dynamic and results-driven leader in the field of diagnostics and biomarker research.